Vigabatrin for childhood partial-onset epilepsies

Pediatric Neurology

Volumn 46, Issue 2, 2012, Pages 83-88

  Greiner, Hansel M ^a   Lynch, Elizabeth R ^a   Fordyce, Steve ^a   Agricola, Karen ^a   Tudor, Cynthia ^a   Franz, David Neal ^a   Krueger, Darcy A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIGABATRIN;

ADOLESCENT; ADULT; BENIGN CHILDHOOD EPILEPSY; CHILD; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANTILE SPASM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SEIZURE; TREATMENT DURATION; TREATMENT RESPONSE; TUBEROUS SCLEROSIS; VISUAL IMPAIRMENT;

EID: 84856112803     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2011.11.020     Document Type: Article

References (40)

1. Lundbeck, Inc Sabril [package insert] 2010 Lundbeck, Inc. Deerfield, IL
2. J.A. French, M. Mosier, S. Walker, K. Sommerville, and N. Sussman A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures: Vigabatrin Protocol 024 Investigative Cohort Neurology 46 1996 54 61 (Pubitemid 26156102)
3. R.E. Appleton, A.C. Peters, J.P. Mumford, and D.E. Shaw Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms Epilepsia 40 1999 1627 1633 (Pubitemid 29518094)
4. C. Dean, M. Mosier, and K. Penry Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures Epilepsia 40 1999 74 82 (Pubitemid 29031756)
5. R.D. Elterman, W.D. Shields, R.M. Bittman, S.A. Torri, S.M. Sagar, and S.D. Collins Vigabatrin for the treatment of infantile spasms: Final report of a randomized trial J Child Neurol 25 2010 1340 1347
6. R.D. Elterman, W.D. Shields, K.A. Mansfield, J. Nakagawa US Infantile Spasms Vigabatrin Study Group Randomized trial of vigabatrin in patients with infantile spasms Neurology 57 2001 1416 1421 (Pubitemid 32995722)
7. A.L. Lux, S.W. Edwards, and E. Hancock The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomised trial Lancet Neurol 4 2005 712 717 (Pubitemid 41457286)
8. S. Camposano, P. Major, E. Halpern, and E. Thiele Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile Epilepsia 49 2008 1186 1191 (Pubitemid 351991397)
9. E. Hancock, and J. Osborne Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review J Child Neurol 14 1999 71 74 (Pubitemid 29146614)
10. K. Hemming, M.J. Maguire, J.L. Hutton, and A.G. Marson Vigabatrin for refractory partial epilepsy Cochrane Database Syst Rev 16 2008 CD007302
11. H. Fledelius Vigabatrin-associated visual field constriction in a longitudinal series: Reversibility suggested after drug withdrawal Acta Ophthalmol Scand 81 2003 41 46
12. P. Kinirons, G. Cavalleri, and D. O'Rourke Vigabatrin retinopathy in an Irish cohort: Lack of correlation with dose Epilepsia 47 2006 311 317
13. P. Parisi, R. Bombardieri, and P. Curatolo Current role of vigabatrin in infantile spasms Eur J Paediatr Neurol 11 2007 331 336 (Pubitemid 47541933)
14. T. Eke, J.F. Talbot, and M.C. Lawden Severe persistent visual field constriction associated with vigabatrin Br Med J [Clin Res] 314 1997 180 181 (Pubitemid 27037871)
15. N.R. Miller, M.A. Johnson, and S.R. Paul Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings Neurology 53 1999 2082 2087
16. B. Schmitz, T. Schmidt, B. Jokiel, S. Pfeiffer, K. Tiel-Wilck, and K. Rüther Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: A prospective study J Neurol 249 2002 469 475 (Pubitemid 34304624)
17. P.A. Gonzalez, A. McCall, A. McQuistan, D. Keating, M. Brodie, and S. Parks Assessing retinal toxicity of vigabatrin and other GABA-ergic drugs in patients with epilepsy Invest Ophthalmol Vis Sci 46 2006 1658
18. J.W. Wheless, R.E. Ramsay, and S.D. Collins Vigabatrin Neurotherapeutics 4 2007 163 172 (Pubitemid 46107327)
19. E.J. Waterhouse, K.N. Mims, and S.N. Gowda Treatment of refractory complex partial seizures: Role of vigabatrin Neuropsychiatr Dis Treat 5 2009 505 515
20. J.M. Wild, C. Chiron, and H. Ahn Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: Final results from an open-label, observational, multicentre study CNS Drugs 23 2009 965 982
21. M.J. Maguire, K. Hemming, J.M. Wild, J.L. Hutton, and A.G. Marson Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review Epilepsia 51 2010 2423 2431
22. D.A. Krueger, and D.N. Franz Current management of tuberous sclerosis complex Paediatr Drugs 10 2008 299 313
23. M. Hyman, and V. Whittemore National Institutes of Health consensus conference: Tuberous sclerosis complex Arch Neurol 57 2000 662 665 (Pubitemid 30252800)
24. E.S. Roach, F.J. DiMario, R.S. Kandt, and H. Northrup Tuberous Sclerosis Consensus Conference: Recommendations for diagnostic evaluation J Child Neurol 14 1999 401 407 (Pubitemid 29321101)
25. L. Gram, P. Klosterskov, and M. Dam Gamma-vinyl GABA: A double-blind placebo-controlled trial in partial epilepsy Ann Neurol 17 1985 262 266 (Pubitemid 15136600)
26. P. Loiseau, J.P. Hardenberg, M. Pestre, M. Guyot, P.J. Schechter, and G.P. Tell Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy Epilepsia 27 1986 115 120 (Pubitemid 16071851)
27. E.M. Rimmer, and A. Richens Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy Lancet 1 1984 189 190 (Pubitemid 14221991)
28. A. Tartara, R. Manni, C.A. Galimberti, J. Hardenberg, J. Orwin, and E. Perucca Vigabatrin in the treatment of epilepsy: A double-blind, placebo-controlled study Epilepsia 27 1986 717 723 (Pubitemid 17226912)
29. C. Chiron, O. Dulac, D. Beaumont, L. Palacios, N. Pajot, and J. Mumford Therapeutic trial of vigabatrin in refractory infantile spasms J Child Neurol 6 Suppl. 2 1991 S52 S59
30. B. Schmitt, G. Wohlrab, and E. Boltshauser Vigabatrin in newly diagnosed infantile spasms Neuropediatrics 25 1994 54 (Pubitemid 24102274)
31. F. Vigevano, and M.R. Cilio Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study Epilepsia 38 1997 1270 1274 (Pubitemid 28007515)
32. R.C. Sergott, R.M. Bittman, E.M. Christen, and S.M. Sagar Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy Epilepsy Res 92 2010 170 176
33. E. Gaily, H. Jonsson, and M. Lappi Visual fields at school-age in children treated with vigabatrin in infancy Epilepsia 50 2009 206 216
34. A.A. Akakaya, S. Gökeer, and H.H. Erbil Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy Eur J Ophthalmol 20 2010 763 769
35. F. Jammoul, Q. Wang, and R. Nabbout Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity Ann Neurol 65 2009 98 107
36. J.M. Pellock, R. Hrachovy, and S. Shinnar Infantile spasms: A U.S. consensus report Epilepsia 51 2010 2175 2189
37. L. Carmant Vigabatrin therapy for infantile spasms: Review of major trials in Europe, Canada, and the United States; and recommendations for dosing Acta Neurol Scand 124 Suppl. 192 2011 136 147
38. R.C. Sergott, J.W. Wheless, and M.C. Smith Evidence-based review of recommendations for visual function testing in patients treated with vigabatrin Neuroophthalmology 34 2010 20 35
39. K. Valente, C. Koiffmann, and C. Fridman Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13 Arch Neurol 63 2006 122 128 (Pubitemid 43063870)
40. B. Ceulemans, M. Boel, and L. Claes Severe myoclonic epilepsy in infancy: Toward an optimal treatment J Child Neurol 19 2004 516 521 (Pubitemid 39481251)